Aptevo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aptevo Therapeutics

08/08/2024 15:47

* Aptevo Therapeutics Inc  APVO.OQ  reported a quarterly
adjusted
loss of $1.67​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of $-54.12.  The mean expectation of two analysts for the
quarter was for a loss of $6.55 per share. Wall Street expected
results to range from $-11.17 to $-1.93 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aptevo Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.67​.
    * The company reported a quarterly loss of $5.88 million.
    * Aptevo Therapeutics Inc shares had risen by 35.9% this
quarter and lost 94.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $13.75 
This summary was machine generated from LSEG data August 8 at
02:47 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -6.55          -1.67          Beat
 Mar. 31 2024      -12.84         -9.95          Beat
 Dec. 31 2023      -18.04         -6.16          Beat
 Sep. 30 2023      -33.00         -22.00         Beat